MedDataX Logo

Therapeutic Literacy Evaluation in Liver Transplanted Patients

NCT ID: NCT04189380

Last Updated: 2020-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-23

Study Completion Date

2019-06-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Health literacy is a new concept in therapeutic patient education. Health Literacy has been defined as the cognitive and social skills which determine the motivation and ability of individuals to gain access to, understand and use information in ways which promote and maintain good health. Health literacy seems predictive of adherence 's patients to treatment or positive health behavior.

Liver transplanted patients need to modify their lifestyle and to perform new behaviors in order to improve their survival and their quality of life. Health literacy evaluation in these patients is necessary to know what they understand and to improve their intake.

The Aim of the study is to evaluate health literacy among liver transplanted patient and to perform liver transplanted patient profiles related to their own health literacy.

The second aim is to study the impact of health literacy on medication adherence and iatrogenic hospitalizations It is a monocentric non-randomized study. During the hepatologist consultation, the HLQ Health Literacy Questionnaire is performed to explore patient health understanding and perception. Then the pharmacist interviews the patient to explore motivations and brakes for their own healthcare; Furthermore, a cognitive and precarity evaluation is performed in order to analyze psychological or social factors which can influence health literacy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tests performed:

* Health Literacy Questionnaire: HLQ
* Montreal Cognitive Evaluation Assessment: MoCA
* EPICES: precarity test validated in French
* A qualitative interview

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Literacy Liver Transplantation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Health literacy liver transplanted patients cognitive evaluation social status

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort 1

liver transplanted patient

Group Type EXPERIMENTAL

HLQ (Health literacy questionnaire)

Intervention Type OTHER

each patient complete survey and self-assessment questionnaire before or after his medical consultation

MoCA (Montreal Cognitive Assessment)

Intervention Type OTHER

each patient complete survey and self-assessment questionnaire before or after his medical consultation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HLQ (Health literacy questionnaire)

each patient complete survey and self-assessment questionnaire before or after his medical consultation

Intervention Type OTHER

MoCA (Montreal Cognitive Assessment)

each patient complete survey and self-assessment questionnaire before or after his medical consultation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient \> 18 years
* Liver transplanted patient \> 1 year at the start of the study
* patient who are followed-up by an hepatologist in the center
* patient who understands and speaks French

Exclusion Criteria

* patient not yet liver transplanted (on the waiting-list)
* patient who has not come back home yet
* patient who does not speak or understand French
* patient refusal to participate
* patient under supervision or guardianship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Talavera

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Clermont-Ferrand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Clermont Ferrand

Clermont-Ferrand, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A01031-54

Identifier Type: OTHER

Identifier Source: secondary_id

RBHP 2018 TALAVERA

Identifier Type: -

Identifier Source: org_study_id